Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071
Published February 27, 2019 · Recall initiated: February 19, 2019
Summary
FDA records drug Class III recall D-0516-2019, published February 27, 2019 and initiated February 19, 2019. Recalling firm: Amerigen Pharmaceuticals Inc.; Status: Terminated; Reported quantity: a) 2,413 bottles b) 3,355 bottles; Lot: Lot #: a) 18J043A, Exp 09/30/2020, b) 18J043B, Exp 09/30/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Amerigen Pharmaceuticals Inc.
- Distributor
- Product was distributed to 4 wholesalers/distributors and 1 retail account who may have further distribute the product throughout the United States.
- Lot
- Lot #: a) 18J043A, Exp 09/30/2020, b) 18J043B, Exp 09/30/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClobetasol Propionate Emollient Cream 0.05%, a) 30 gram (NDC 50383-270-30) and b) 60 gram (NDC 50383-270-60)February 27, 2019
- FDAARDENT H&R SR FLR, 25LB, 50 LB, and 25LB (PC)-309951, packaged in paper bags, Store at Ambient TemperatureFebruary 27, 2019
- FDACiclopirox shampoo 1%,120 mL bottle, Rx only, Manufactured By Perrigo Bronx, NY 10457 Distributed by PerrigoFebruary 27, 2019
- FDAHILLTOP HEARTH SELF RISE FLR 25LB and 50LBFebruary 27, 2019
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, 100-count bottle, Rx only, Mfd.By: Dr. Reddy'sFebruary 27, 2019
- FDATemozolomide capsules, 20 mg, packaged in a) 5-count bottle(NCD 43975-253-05), b) 14-count bottle (NDCOctober 24, 2018
Questions about this recall
Was Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071 recalled?
Yes. FDA published recall D-0516-2019 on February 27, 2019. Reported hazard: Failed dissolution specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter